MHS Faculty Research Series | Professor Gordon Jayson and Dr Ross Little
|Starts:||12:30 27 Nov 2013|
|Ends:||14:00 27 Nov 2013|
|What is it:||Seminar|
|Organiser:||Institute of Cancer Sciences|
|Who is it for:||Adults, Current University students, University staff|
Host: Institute of Cancer Sciences and Institute of Population Health
Professor Gordon Jayson, Institute of Cancer Sciences, “Defining predictive biomarkers of benefit from anti-angiogenic therapies in cancer”
Gordon Jayson qualified in Medicine at the University of Oxford. His subsequent medical and oncology training took place in Manchester and the Christie Hospital. Following a PhD in heparan sulfate biology, he has conducted post-doctoral research that aims to translate the new data from heparan sulfate biology into the clinic. His current programme of work, described above, is directed at the laboratory development of novel oligosaccharides as anti-angiogenic agents and the early and late clinical trial evaluation of this class of drugs. The latter programme aims to identify serological and imaging based biomarkers that will identify the patients who are most likely to benefit from these agents and which will be used to underpin the development of combination regimens of biological agents. This work is largely focused on ovarian cancer, the disease that Professor Jayson looks after in Christie Hospital.
Junior Presenter: Dr Ross Little, Institute of Population Health: “The Travastin study - a quantitative MRI perspective”
Ross' background is in computer science and mathematics, and for his PhD he researched the challenges of arterial input function acquisition in the context of dynamic contrast-enhanced (DCE) MRI. He is interested in improving quantitative MRI measurements, both within the context of DCE-MRI and in wider settings, for example through the use of domain-appropriate undersampling strategies. His work has involved the development of custom physical phantoms, as well as novel data processing methods, to support clinical data acquisition. He manages the clinical trials of the Quantitative Biomedical Imaging (QBI) Lab in the Centre for Imaging Sciences, which researches a number of quantitative MRI measurements and develops collaborations to collect and interpret physiologically-relevant measurements to monitor, for example, the response of patients to novel therapeutic interventions.
About the Faculty Research Series:
- These are monthly events that are open to all staff and students from across the Faculty of Medical and Human Sciences and the University, offering an opportunity to celebrate research achievement and stimulate scientific interaction. Each month, one host School or Institute from the Faculty will pair with a different School or Institute to highlight and showcase similar topics from different perspectives.
- The 2013 series is being led by Professor David Eisner and administered from the Faculty Research Office.
- Held on Wednesday lunchtimes, each meeting lasts an hour, including two 20-25 minute presentations – one from a junior and one from a more senior member of Faculty staff.
- Each presentation will be followed by a short discussion.
- A buffet lunch will be available from 12.30 pm.
- Presentations begin: 1.00 pm.
- Final details of presentation topics and speakers will be posted nearer the date.
Travel and Contact Information
Ronald Lane Lecture Room, Room 2.823/2.825